idh inhibition in aml therapy
Published 6 years ago • 55 plays • Length 2:50Download video MP4
Download video MP3
Similar videos
-
1:44
improving maintenance therapy in aml: exploring the role of idh inhibitors
-
3:14
updates on idh inhibition in aml
-
1:32
idh inhibitors for aml and mds
-
0:59
idh inhibitors in aml
-
0:54
idh inhibitors and the evolving aml treatment paradigm
-
4:10
explore idh mutations
-
2:33
novel immunotherapies in aml and insights into the future of the treatment landscape
-
3:23
the prognostic value of idh1 and idh2 in acute myeloid leukemia (aml)
-
3:08
venetoclax-idh inhibitor combination therapy for aml
-
1:45
deciding which patients with mpns are suitable candidates for interferon-based therapy
-
2:44
the global expansion of modern aml therapy through the international consortium on acute leukemia
-
1:23
decitabine, venetoclax, and idh inhibitor in idh-mutated aml
-
2:08
the impact of idh mutations on the outcomes of patients with aml & inhibitors under investigation
-
2:13
a success story: idh inhibitors for aml
-
1:25
idh inhibitors for aml: highlights from ash 2018
-
1:51
idh1/2 inhibitors for upfront aml therapy and transfusion independence
-
1:53
treatment strategies for patients with idh1/2-mutated aml ineligible for intensive chemotherapy
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
1:48
idh1 inhibitor ivosidenib for the treatment of relapsed/ refractory aml
-
2:57
targeting idh mutations for the treatment of aml
-
1:21
trends in allosct for good-risk aml: a longitudinal study